SFRP1 and neoplasm: A study in 2011 found that SFRP-1 and the SFRP-like molecule V3Nter can inhibit β-catenin-activated tumor cells growth in vivo, though another study argues that sFRPs have dual effects on Wnt/β-catenin signaling depending on various factors (95, 96).